Skip to main content
Industry News
Regeneron seeks EUA for antibody cocktail
10/9/2020

Regeneron Pharmaceuticals said it has filed an application with the FDA seeking emergency use authorization for the experimental antibody cocktail used to treat President Donald Trump for COVID-19. If granted an EUA, the company said it has doses for 50,000 people available and expects to be able to treat 300,000 within a few months.

Full Story: